The estimated Net Worth of Randall M. Toig is at least $22.5 millier dollars as of 11 December 2020. Randall Toig owns over 10,000 units of Cyclo Therapeutics stock worth over $22,491 and over the last 4 years Randall sold CYTH stock worth over $0.
Randall has made over 1 trades of the Cyclo Therapeutics stock since 2020, according to the Form 4 filled with the SEC. Most recently Randall bought 10,000 units of CYTH stock worth $6,600 on 11 December 2020.
The largest trade Randall's ever made was buying 10,000 units of Cyclo Therapeutics stock on 11 December 2020 worth over $6,600. On average, Randall trades about 714 units every 0 days since 2020. As of 11 December 2020 Randall still owns at least 34,078 units of Cyclo Therapeutics stock.
You can see the complete history of Randall Toig stock trades at the bottom of the page.
Randall's mailing address filed with the SEC is C/O CYCLO THERAPEUTICS, INC., 6714 NW 16TH STREET, SUITE B, GAINESVILLE, FL, 32653.
Over the last 4 years, insiders at Cyclo Therapeutics have traded over $0 worth of Cyclo Therapeutics stock and bought 4,648,141 units worth $6,142,223 . The most active insiders traders include Holdings, Inc. Rafael, Shawn Cross et N Scott Fine. On average, Cyclo Therapeutics executives and independent directors trade stock every 25 days with the average trade being worth of $78,661. The most recent stock trade was executed by Holdings, Inc. Rafael on 1 August 2023, trading 4,000,000 units of CYTH stock currently worth $5,000,000.
Cyclo Therapeutics, Inc., a clinical stage biotechnology company, develops cyclodextrin-based products for the treatment of various diseases. Its lead drug candidate is Trappsol Cyclo, an orphan drug, which is Phase III clinical trials for the treatment of Niemann-Pick Type C disease. The company also develops Trappsol Cyclo for the treatment of Alzheimer's disease. In addition, it sells cyclodextrins and related products to the pharmaceutical, nutritional, and other industries, primarily for use in diagnostics and specialty drugs. The company was formerly known as CTD Holdings, Inc. and changed its name to Cyclo Therapeutics, Inc. in September 2019. Cyclo Therapeutics, Inc. was incorporated in 1990 and is based in Gainesville, Florida.
Cyclo Therapeutics executives and other stock owners filed with the SEC include: